Soluble, low molecular weight delivery agents provide a novel approach
to the mucosal delivery of antigens. These compounds are easily synth
esized by conventional chemical methods, and may be dissolved directly
in an antigen solution/suspension for convenient administration. Prel
iminary screening studies are described in which antigen-specific secr
etory IgA (fecal and salivary) and systemic responses (circulating ant
i-ovalbumin isotypes and antigen-specific delayed-type hypersensitivit
y) were induced by dosing ovalbumin together with various delivery age
nts with orally or colonically. The data suggest that delivery agents
facilitate transport of antigenically intact ovalbumin through the muc
osa of both the upper and lower gastro-intestinal tracts. The possible
mechanism of action and potential applications are discussed.